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BATES-JENSEN WOUND ASSESSMENT TOOL 
Instructions for use 
 
Fill out the attached rating sheet to assess a wound’s status after reading the definitions and methods of assessment 
described below. Evaluate once a week and whenever a change occurs in the wound. Rate according to each item by 
picking the response that best describes the wound and entering that score in the item score column for the appropriate 
date. When you have rated the wound on all items, determine the total score by adding together the 13-item scores. 




1. Size:  Use ruler to measure the longest and widest aspect of the wound surface in centimeters; multiply  length 
x width. 
 
2. Depth:  Pick the depth, thickness, most appropriate to the wound using these additional descriptions: 
1 = tissues damaged but no break in skin surface. 
2 = superficial, abrasion, blister or shallow crater.  Even with, &/or elevated above skin surface (e.g., 
hyperplasia). 
3 = deep crater with or without undermining of adjacent tissue. 
4 = visualization of tissue layers not possible due to necrosis.  
5 = supporting structures include tendon, joint capsule. 
 
3. Edges:  Use this guide: 
Indistinct, diffuse = unable to clearly distinguish wound outline. 
Attached = even or flush with wound base, no sides or walls present; flat. 
Not attached = sides or walls are present; floor or base of wound is deeper than edge. 
Rolled under, thickened = soft to firm and flexible to touch. 
Hyperkeratosis = callous-like tissue formation around wound & at edges. 
Fibrotic, scarred = hard, rigid to touch. 
 
4. Undermining: Assess by inserting a cotton tipped applicator under the wound edge; advance it as far as it 
will go without using undue force; raise the tip of the applicator so it may be seen or felt on the surface of the 
skin; mark the surface with a pen; measure the distance from the mark on the skin to the edge of the wound. 
Continue process around the wound. Then use a transparent metric measuring guide with concentric circles 
divided into 4 (25%) pie-shaped quadrants to help determine percent of wound involved. 
 
5. Necrotic Tissue Type: Pick the type of necrotic tissue that is predominant in the wound according to color, 
consistency and adherence using this guide: 
White/gray non-viable tissue = may appear prior to wound opening; skin surface is 
  white or gray. 
Non-adherent, yellow slough = thin, mucinous substance; scattered throughout wound 
  bed; easily separated from wound tissue. 
Loosely adherent, yellow slough = thick, stringy, clumps of debris; attached to wound 
  tissue. 
Adherent, soft, black eschar = soggy tissue; strongly attached to tissue in center or 
  base of wound. 
Firmly adherent, hard/black eschar = firm, crusty tissue; strongly attached to wound base 
  and edges (like a hard scab). 
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6. Necrotic Tissue Amount: Use a transparent metric measuring guide with concentric circles divided into 4 
(25%) pie-shaped quadrants to help determine percent of wound involved. 
 
7. Exudate Type: Some dressings interact with wound drainage to produce a gel or trap liquid. Before 
assessing exudate type, gently cleanse wound with normal saline or water. Pick the exudate type that is 
predominant in the wound according to color and consistency, using this guide: 
Bloody = thin, bright red 
Serosanguineous = thin, watery pale red to pink 
Serous = thin, watery, clear 
Purulent = thin or thick, opaque tan to yellow 
Foul purulent = thick, opaque yellow to green with offensive odor 
 
8. Exudate Amount: Use a transparent metric measuring guide with concentric circles divided into 4 (25%) 
pie-shaped quadrants to determine percent of dressing involved with exudate.  Use this guide: 
None = wound tissues dry. 
Scant = wound tissues moist; no measurable exudate. 
Small = wound tissues wet; moisture evenly distributed in wound; drainage 
  involves < 25% dressing. 
Moderate = wound tissues saturated; drainage may or may not be evenly distributed 
  in wound; drainage involves > 25% to < 75% dressing. 
Large = wound tissues bathed in fluid; drainage freely expressed; may or may not 
  be evenly distributed in wound; drainage involves > 75% of dressing. 
 
9. Skin Color Surrounding Wound: Assess tissues within 4cm of wound edge. Dark-skinned persons show 
the colors "bright red" and "dark red" as a deepening of normal ethnic skin color or a purple hue. As healing 
occurs in dark-skinned persons, the new skin is pink and may never darken. 
 
10. Peripheral Tissue Edema & Induration: Assess tissues within 4cm of wound edge. Non-pitting edema 
appears as skin that is shiny and taut. Identify pitting edema by firmly pressing a finger down into the tissues 
and waiting for 5 seconds, on release of pressure, tissues fail to resume previous position and an indentation 
appears. Induration is abnormal firmness of tissues with margins. Assess by gently pinching the tissues. 
Induration results in an inability to pinch the tissues. Use a transparent metric measuring guide to determine 
how far edema or induration extends beyond wound. 
 
11. Granulation Tissue:  Granulation tissue is the growth of small blood vessels and connective tissue to fill in 
full thickness wounds. Tissue is healthy when bright, beefy red, shiny and granular with a velvety appearance. 
Poor vascular supply appears as pale pink or blanched to dull, dusky red color. 
 
12. Epithelialization: Epithelialization is the process of epidermal resurfacing and appears as pink or red skin. In 
partial thickness wounds it can occur throughout the wound bed as well as from the wound edges. In full 
thickness wounds it occurs from the edges only. Use a transparent metric measuring guide with concentric 
circles divided into 4 (25%) pie-shaped quadrants to help determine percent of wound involved and to 
measure the distance the epithelial tissue extends into the wound. 
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BATES-JENSEN WOUND ASSESSMENT TOOL NAME 
Complete the rating sheet to assess wound status. Evaluate each item by picking the response that best describes the 
wound and entering the score in the item score column for the appropriate date. 
 
Location: Anatomic site. Circle, identify right (R) or left (L) and use "X" to mark site on body diagrams: 
   Sacrum & coccyx    Lateral ankle  
   Trochanter    Medial ankle  
   Ischial tuberosity    Heel Other Site 
 
Shape: Overall wound pattern; assess by observing perimeter and depth. 














1. Size 1 = Length x width <4 sq cm 
2 = Length x width  4--<16 sq cm 
3 = Length x width 16.1--<36 sq cm 
4 = Length x width 36.1--<80 sq cm 
5 = Length x width >80 sq cm 
   
2. Depth 1 = Non-blanchable erythema on intact skin 
2 = Partial thickness skin loss involving epidermis &/or dermis 
3 = Full thickness skin loss involving damage or necrosis of subcutaneous 
tissue; may extend down to but not through underlying fascia; &/or 
mixed partial & full thickness &/or tissue layers obscured by 
granulation tissue 
4 = Obscured by necrosis 
5 = Full thickness skin loss with extensive destruction, tissue necrosis or 
damage to muscle, bone or supporting structures 
   
3. Edges 1 = Indistinct, diffuse, none clearly visible 
2 = Distinct, outline clearly visible, attached, even with wound base 
3 = Well-defined, not attached to wound base 
4 = Well-defined, not attached to base, rolled under, thickened 
5 = Well-defined, fibrotic, scarred or hyperkeratotic 
   
4. Under- 
mining 
1 = None present 
2 =Undermining < 2 cm in any area 
3 = Undermining 2-4 cm involving < 50% wound margins 
4 = Undermining 2-4 cm involving > 50% wound margins 
5 = Undermining > 4 cm or Tunneling in any area 




1 = None visible 
2 = White/grey non-viable tissue &/or non-adherent yellow slough 
3 = Loosely adherent yellow slough 
4 = Adherent, soft, black eschar 
5 = Firmly adherent, hard, black eschar 




1 = None visible 
2 = < 25% of wound bed covered 
3 = 25% to 50% of wound covered 
4 = > 50% and < 75% of wound covered 
5 = 75% to 100% of wound covered 
   
7. Exudate 
Type 
1 = None    
   Irregular    Linear or elongated 
   Round/oval    Bowl/boat 












 2 = Bloody 
3 = Serosanguineous: thin, watery, pale red/pink 
4 = Serous:  thin, watery, clear 
5 = Purulent: thin or thick, opaque, tan/yellow, with or without odor 
   
8. Exudate 
Amount 
1 = None, dry wound 
2 = Scant, wound moist but no observable exudate 
3 = Small 
4 = Moderate 
5 = Large 






1 = Pink or normal for ethnic group 
2 = Bright red &/or blanches to touch 
3 = White or grey pallor or hypopigmented 
4 = Dark red or purple &/or non-blanchable 
5 = Black or hyperpigmented 





1 = No swelling or edema 
2 = Non-pitting edema extends <4 cm around wound 
3 = Non-pitting edema extends >4 cm around wound 
4 = Pitting edema extends < 4 cm around wound 
5 = Crepitus and/or pitting edema extends >4 cm around wound 





1 = None present 
2 = Induration, < 2 cm around wound 
3 = Induration 2-4 cm extending < 50% around wound 
4 = Induration 2-4 cm extending > 50% around wound 
5 = Induration > 4 cm in any area around wound 




1 = Skin intact or partial thickness wound 
2 = Bright, beefy red; 75% to 100% of wound filled &/or tissue 
overgrowth 
3 = Bright, beefy red; < 75% & > 25% of wound filled 
4 = Pink, &/or dull, dusky red &/or fills < 25% of wound 
5 = No granulation tissue present 




1 = 100% wound covered, surface intact 
2 = 75% to <100% wound covered &/or epithelial tissue 
extends >0.5cm  into wound bed 
3 = 50% to <75% wound covered &/or epithelial tissue 
extends to <0.5cm  into wound bed 
4 = 25% to < 50% wound covered 
5 = < 25% wound covered 
   
 
TOTAL SCORE 
   
 
SIGNATURE 






WOUND STATUS CONTINUUM 
 
 
1 5 10  13 15 20 25 30 35 40 45 50 55 60 




Plot the total score on the Wound Status Continuum by putting an "X" on the line and the date beneath the line. 
Plot multiple scores with their dates to see-at-a-glance regeneration or degeneration of the wound. 
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Lampiran 4. Hasil Skoring 
 Hari ke-1 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
3 Edges 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 2 3 2 2 2 2 2 2 2 2 2 2 3 2 2 2 2 2 2 3 
6 Necrotic tissue amount 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 











 Hari ke-2 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
3 Edges 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 2 3 2 2 2 2 2 2 2 2 2 2 3 2 2 2 2 2 2 3 
6 Necrotic tissue amount 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 











 Hari ke-3 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
3 Edges 3 3 3 3 3 2 3 2 3 2 2 3 3 3 2 3 3 3 3 3 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 2 3 2 2 2 2 2 2 2 2 2 2 3 2 2 2 2 2 2 3 
6 Necrotic tissue amount 5 5 5 5 4 5 5 5 5 5 5 5 5 5 4 5 4 5 5 5 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 












 Hari ke-4 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
3 Edges 3 3 3 3 3 2 2 3 2 2 2 2 2 2 2 3 2 3 3 3 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 2 3 2 2 2 2 2 2 2 2 2 2 3 2 2 2 2 2 2 3 
6 Necrotic tissue amount 5 5 5 5 4 4 5 4 4 4 4 4 4 4 3 4 3 4 4 4 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 5 












 Hari ke-5 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
3 Edges 3 3 3 3 3 2 2 2 2 2 2 2 2 2 2 3 2 3 3 3 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 2 3 2 2 2 2 3 2 2 2 2 2 3 2 2 2 2 2 2 2 
6 Necrotic tissue amount 4 4 4 4 3 3 4 3 3 3 3 3 3 3 2 3 2 3 3 3 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 2 1 2 1 1 1 2 1 1 2 2 1 1 1 2 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 5 5 5 5 5 5 5 4 5 4 5 4 5 5 4 4 4 5 5 4 












 Hari ke-6 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 2 2 2 2 2 2 2 1 2 1 2 2 2 2 2 2 2 2 2 2 
3 Edges 3 2 2 2 3 2 2 2 2 2 2 2 2 2 2 2 2 2 2 2 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 2 2 2 2 2 2 3 1 2 1 2 2 2 2 2 2 2 3 3 3 
6 Necrotic tissue amount 4 3 2 3 3 2 3 1 2 1 2 3 2 3 2 2 2 3 3 3 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 2 1 2 1 1 1 2 1 1 2 2 1 1 1 2 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 5 4 4 5 5 4 4 4 4 3 4 3 4 4 3 3 3 4 4 3 












 Hari ke-7 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 2 2 2 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 
3 Edges 1 2 2 1 2 2 2 1 1 2 2 2 2 2 2 2 2 2 2 2 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 2 2 2 1 1 1 1 1 1 1 2 2 2 2 2 2 2 2 2 2 
6 Necrotic tissue amount 2 2 2 1 1 1 1 1 1 1 2 2 2 2 2 2 2 3 2 3 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 4 4 4 5 5 3 3 3 3 2 4 3 4 3 2 3 3 4 4 3 












 Hari ke-8 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 1 2 2 2 2 1 1 1 1 1 2 2 2 2 1 2 1 2 1 1 
3 Edges 1 2 2 2 2 1 1 1 1 1 2 2 2 2 1 1 1 1 1 1 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 1 2 2 2 2 1 1 1 1 1 2 2 2 2 1 2 1 2 1 1 
6 Necrotic tissue amount 1 2 2 2 2 1 1 1 1 1 2 2 2 2 1 2 1 2 1 1 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 1 1 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 3 4 3 4 4 3 3 2 2 2 3 3 3 3 3 2 2 4 4 3 












 Hari ke-9 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 1 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
3 Edges 1 1 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 1 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
6 Necrotic tissue amount 1 2 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 2 3 3 3 3 1 1 2 1 2 3 2 3 3 2 2 2 3 3 3 













 Hari ke-10 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
3 Edges 1 2 1 2 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
6 Necrotic tissue amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 2 2 2 2 2 1 1 1 1 1 1 1 2 1 1 1 1 3 1 1 











 Hari ke-11 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
3 Edges 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
6 Necrotic tissue amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 2 2 1 1 2 1 1 1 1 1 1 1 2 1 2 1 1 2 1 1 












 Hari ke-12 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
3 Edges 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
6 Necrotic tissue amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 












 Hari ke-13 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
3 Edges 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
6 Necrotic tissue amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 












 Hari ke-14 
 
NO ITEM 
GROUP 1 GROUP 2 GROUP 3 GROUP 4 
A B C D E A B C D E A B C D E A B C D E 
1 Size 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
2 Depth 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
3 Edges 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
4 Undermining 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
5 Necrotic tissue type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
6 Necrotic tissue amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
7 Exudate type 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
8 Exudate amount 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
9 Skin color surrounding wound 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
10 Peripheral tissue edema 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
11 Peripheral tissue induration 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
12 Ganulation tissue 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
13 Epithelization 1 1 1 1 2 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 
  TOTAL SCORE 13 13 13 13 15 13 13 13 13 13 13 13 13 13 13 13 13 13 13 13 
 









5 5 5 5 5
26.20 26.20 26.00 26.00 24.40
.447 .447 .707 .707 .548
26.00 26.00 26.00 26.00 24.00
26 26 25 25 24
27 27 27 27 25
5 5 5 5 5
26.00 26.00 25.40 24.40 22.20
.000 .000 .548 .548 1.304
26.00 26.00 25.00 24.00 22.00
26 26 25 24 21
26 26 26 25 24
5 5 5 5 5
26.20 26.20 25.60 24.00 22.00
.447 .447 1.140 .707 1.414
26.00 26.00 26.00 24.00 22.00
26 26 24 23 20
27 27 27 25 24
5 5 5 5 5
26.20 26.20 26.00 24.80 22.20
.447 .447 .707 1.095 .837
26.00 26.00 26.00 25.00 22.00
26 26 25 23 21
27 27 27 26 23
20 20 20 20 20
26.15 26.15 25.75 24.80 22.70
.366 .366 .786 1.056 1.418
26.00 26.00 26.00 25.00 22.50
26 26 24 23 20









































5 5 5 5 5
22.40 19.00 18.80 17.40 14.60
1.517 1.225 2.168 2.408 .548
22.00 19.00 20.00 18.00 15.00
21 17 15 14 14
24 20 20 20 15
5 5 5 5 5
19.20 15.40 14.60 13.40 13.00
2.588 .548 .548 .548 .000
20.00 15.00 15.00 13.00 13.00
16 15 14 13 13
22 16 15 14 13
5 5 5 5 5
20.40 19.20 18.20 14.60 13.20
.894 .837 1.789 .548 .447
21.00 19.00 19.00 15.00 13.00
19 18 15 14 13
21 20 19 15 14
5 5 5 5 5
20.80 19.80 16.20 14.60 13.40
1.304 .837 1.924 .548 .894
21.00 20.00 16.00 15.00 13.00
19 19 14 14 13
22 21 19 15 15
20 20 20 20 20
20.70 18.35 16.95 15.00 13.55
1.949 1.954 2.328 1.919 .826
21.00 19.00 16.50 14.50 13.00
16 15 14 13 13











































5 5 5 5
13.80 13.40 13.40 13.40
.837 .894 .894 .894
14.00 13.00 13.00 13.00
13 13 13 13
15 15 15 15
5 5 5 5
13.00 13.00 13.00 13.00
.000 .000 .000 .000
13.00 13.00 13.00 13.00
13 13 13 13
13 13 13 13
5 5 5 5
13.40 13.00 13.00 13.00
.548 .000 .000 .000
13.00 13.00 13.00 13.00
13 13 13 13
14 13 13 13
5 5 5 5
13.20 13.00 13.00 13.00
.447 .000 .000 .000
13.00 13.00 13.00 13.00
13 13 13 13
14 13 13 13
20 20 20 20
13.35 13.10 13.10 13.10
.587 .447 .447 .447
13.00 13.00 13.00 13.00
13 13 13 13





































H11 H12 H13 H14
 
Tests of Normalityb,c,d,e ,f,g,h,i,j,k,l,m,n
.473 5 .001 .552 5 .000
.473 5 .001 .552 5 .000
.473 5 .001 .552 5 .000
.473 5 .001 .552 5 .000
.473 5 .001 .552 5 .000
.473 5 .001 .552 5 .000
.300 5 .161 .883 5 .325
.367 5 .026 .684 5 .006
.237 5 .200* .961 5 .814
.300 5 .161 .883 5 .325
.300 5 .161 .883 5 .325
.367 5 .026 .684 5 .006
.300 5 .161 .883 5 .325
.372 5 .022 .828 5 .135
.367 5 .026 .684 5 .006
.221 5 .200* .902 5 .421
.300 5 .161 .883 5 .325
.231 5 .200* .881 5 .314
.254 5 .200* .803 5 .086
.221 5 .200* .915 5 .501
.349 5 .046 .771 5 .046
.221 5 .200* .902 5 .421
.300 5 .161 .833 5 .146
.367 5 .026 .684 5 .006
.231 5 .200* .881 5 .314
.231 5 .200* .881 5 .314
.337 5 .066 .676 5 .005
.367 5 .026 .684 5 .006
.473 5 .001 .552 5 .000
.141 5 .200* .979 5 .928
.198 5 .200* .957 5 .787
.367 5 .026 .684 5 .006
.367 5 .026 .684 5 .006
.367 5 .026 .684 5 .006
.367 5 .026 .684 5 .006
.473 5 .001 .552 5 .000
.473 5 .001 .552 5 .000
.231 5 .200* .881 5 .314
.367 5 .026 .684 5 .006
.473 5 .001 .552 5 .000
.473 5 .001 .552 5 .000
.473 5 .001 .552 5 .000































































This is a lower bound of the true significance.*. 
Lilliefors Significance Correctiona. 
H1 is constant when Group = Group 2. It has been omitted.b. 
H2 is constant when Group = Group 2. It has been omitted.c. 
H10 is constant when Group = Group 2. It has been omitted.d. 
H11 is constant when Group = Group 2. It has been omitted.e. 
H12 is constant when Group = Group 2. It has been omitted.f. 
H12 is constant when Group = Group 3. It has been omitted.g. 
H12 is constant when Group = Group 4. It has been omitted.h. 
H13 is constant when Group = Group 2. It has been omitted.i. 
H13 is constant when Group = Group 3. It has been omitted.j. 
H13 is constant when Group = Group 4. It has been omitted.k. 
H14 is constant when Group = Group 2. It has been omitted.l. 
H14 is constant when Group = Group 3. It has been omitted.m. 














































Test of Homogeneity of Variances
2.370 3 16 .109
2.370 3 16 .109
1.119 3 16 .371
.394 3 16 .759
.653 3 16 .593
4.708 3 16 .015
.314 3 16 .815
1.115 3 16 .372
8.443 3 16 .001
4.014 3 16 .026
5.490 3 16 .009
7.111 3 16 .003
7.111 3 16 .003




















































Chi-Square df Asymp. Sig.
Kruskal Wallis Testa. 






















































N Mean Rank Sum of Ranks
Test Statisticsb
1.000 1.500 .000 1.500 1.000 .000
16.000 16.500 15.000 16.500 16.000 15.000
-2.495 -2.386 -2.668 -2.410 -2.463 -2.835



















H4 H5 H7 H8 H9 H10
Not corrected for ties.a. 






















































N Mean Rank Sum of Ranks
Test Statisticsb
.500 1.500 12.000 6.500 4.000 1.000
15.500 16.500 27.000 21.500 19.000 16.000
-2.578 -2.410 -.111 -1.361 -1.820 -2.545



















H4 H5 H7 H8 H9 H10
Not corrected for ties.a. 






















































N Mean Rank Sum of Ranks
Test Statisticsb
4.000 .000 8.000 4.000 4.000 3.500
19.000 15.000 23.000 19.000 19.000 18.500
-1.894 -2.668 -1.003 -1.809 -1.820 -2.012



















H4 H5 H7 H8 H9 H10
Not corrected for ties.a. 






















































N Mean Rank Sum of Ranks
Test Statisticsb
8.500 12.000 .000 1.500 2.000 10.000
23.500 27.000 15.000 16.500 17.000 25.000
-.956 -.108 -2.668 -2.460 -2.324 -1.000



















H4 H5 H7 H8 H9 H10
Not corrected for ties.a. 






















































N Mean Rank Sum of Ranks
Test Statisticsb
8.000 12.000 .000 5.500 2.000 10.000
23.000 27.000 15.000 20.500 17.000 25.000
-1.017 -.108 -2.668 -1.529 -2.324 -1.000



















H4 H5 H7 H8 H9 H10
Not corrected for ties.a. 






















































N Mean Rank Sum of Ranks
Test Statisticsb
6.000 11.000 8.000 5.500 12.500 12.000
21.000 26.000 23.000 20.500 27.500 27.000
-1.424 -.335 -1.003 -1.565 .000 -.149



















H4 H5 H7 H8 H9 H10
Not corrected for ties.a. 























































































Z Asymp. Sig. (2-tailed)
The sum of negative ranks equals the
sum of positive ranks.
a. 
Based on positive ranks.b. 
Wilcoxon Signed Ranks Testc. 
Group 2 
 



















































































Z Asymp. Sig. (2-tailed)
The sum of negative ranks equals the
sum of positive ranks.
a. 
Based on positive ranks.b. 






















































































Z Asymp. Sig. (2-tailed)
The sum of negative ranks equals the
sum of positive ranks.
a. 
Based on positive ranks.b. 
Based on negative ranks.c. 






















































































Z Asymp. Sig. (2-tailed)
The sum of negative ranks equals the
sum of positive ranks.
a. 
Based on positive ranks.b. 












H1 H2 H3 H4 H5 H6 H7 H8 H9 H10 H11 H12 H13 H14
Group 1 Group 2 Group 3 Group 4
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